Product Benefits
| Core Benefit | Mechanism |
| Superior IOP Reduction | The combination of a $\beta$-blocker and an $\alpha_2$-agonist provides an additive and synergistic effect, leading to a more consistent and pronounced reduction in Intraocular Pressure than either drug alone. |
| Dual Mechanism of Action | Timolol reduces the production of fluid (aqueous humor), while Brimonidine reduces fluid production and simultaneously increases the fluid drainage (outflow), targeting multiple pathways. |
| Neuroprotective Potential | Brimonidine may offer a degree of neuroprotection to the retinal ganglion cells, potentially preserving the optic nerve and vision beyond just lowering the pressure. |
| Prevents Vision Loss | Effectively controlling IOP is the primary goal of glaucoma treatment, helping to slow the progression of optic nerve damage and significantly reducing the risk of irreversible blindness. |
⚠️ Important Safety Note: Glaucoma Combination Drop (Beta-Blocker)
Prescription Use Only: This is a serious medication. Use strictly as prescribed by your ophthalmologist. Do not stop taking it abruptly without medical advice.
Systemic Side Effects: Due to the Timolol (beta-blocker) component, systemic absorption can occur, potentially causing side effects like slow heart rate (bradycardia), low blood pressure (hypotension), and respiratory issues (bronchospasm). It is often contraindicated in patients with bronchial asthma, severe COPD, or certain heart rhythm disorders (e.g., sinus bradycardia, second- or third-degree heart block).
Interactions: Use with extreme caution if you are taking other systemic beta-blockers, blood pressure medications, or CNS depressants.
Customer questions & answers
Customer reviews
0 out of 5